Caplight Directory>Investors>T1D Fund>T1d-fund


T1D Fund

T1D Fund

Boston, Massachusettst1dfund.org

Overview

The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D . Launched in December 2016, its aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D .

Year Founded

2016

AUM

$200M

Portfolio Companies

26

Investments

CompanyDateStageLead
Zag BioOct 2025Series ALead
Kriya TherapeuticsSep 2025Series DCo-investor
Zucara Therapeutics Inc.May 2025Series BCo-investor
Aspect BiosystemsJan 2025Series BCo-investor
Cour PharmaJan 2024Series ACo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2016
AUM$200M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.